Effect of mirtazapine on MNNG-induced gastric adenocarcinoma in rats

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 10, 2012, Pages 4897-4900

  Bilici, Mehmet ^a,b   Cayir, Kerim ^a,b   Tekin, Salim Basol ^a,b   Gundogdu, Cemal ^a,c   Albayrak, Abdulmecit ^a,c   Suleyman, Bahadir ^a,c   Ozogul, Bunyamin ^a,c   Erdemci, Burak ^a,c   Suleyman, Halis ^a,c  

^a ATATURK UNIVERSITY   (Turkey)

^b Department of Internal Medicine   (Turkey)

^c Department of Pathology ^*  (Turkey)

Author keywords

Cisplatin; Gastric cancer; Mirtazapine; MNNG; Prevention; Rat

Indexed keywords

EID: 84874012590     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.10.4897     Document Type: Article

References (33)

1. Baldessarini RJ (2005). Drug therapy of depression and anxiety disorders in 'goodman & gilman's the pharmacological basis of therapeutics'. Brunton LL, Lazo JS and Parker KL (eds). New-York, McGraw-Hill, 11, 429-60.
2. Bearzi I, Brancorsini D, Santinelli AD, et al (1994). Gastric dysplasia: a ten-year follow-up study. Pathol Res Pract, 190, 61-8.
3. Berard RM (2001). Depression and anxiety in oncology: the psychiatrist's perspective. J Clin Psychiatry, 62, 58-61.
4. Bilici M, Ozturk C, Dursun H, et al (2009). Protective effect of mirtazapine on indomethacin-induced ulcer in rats and its relationship with oxidant and antioxidant parameters. Dig Dis Sci, 54, 1868-75.
5. Chabner BA, Amrein PC, Druker B, et al (2006). Antineoplastic agents. in 'goodman and gilman's the pharmacological basis of therapeutics'. Brunton LL, Lazo JS and Parker KL (eds). New-York, McGraw-Hill. 11, 1315-404.
6. Chan AO, Wong BC, Lam SK (2001). Gastric cancer: past, present and future. Can J Gastroenterol, 15, 469-74.
7. Chow WH, Blot WJ, Vaughan TL, et al (1998). Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst, 90, 150-5.
8. Crew KD, Neugut AI (2006). Epidemiology of gastric cancer. World J Gastroenterol, 12, 354-62.
9. De Champlain J, Mueller RA, Axelrod J (1969). Turnover and synthesis of norepinephrine in experimental hypertensionin rats. Circ Res, 25, 285-91.
10. Dursun H, Bilici M, Albayrak F, et al (2009). Antiulcer activity of fluvoxamine in rats and its effect on oxidant and antioxidant parameters in stomach tissue. BMC Gastroenterology, 9, 36.
11. Fenoglio-Preiser C, Carnerio F, Correa P, et al (2000). Gastric carcinoma. In 'WHO classification of tumours, pathology and genetics tumours of the digestive system tumours of the stomach'. hamilton sr, altonen LA (eds). IARC Press Lyon, 39-52.
12. Guldahl M (1977). The effect of trimipramine (Surmontil r) on masked depression in patients with duodenal ulcer. A double-blind study. Scand J Gastroenterol, 43, 27-31.
13. Hishida A, Matsuo K, Goto Y, et al (2010). Smoking behavior and risk of Helicobacter pylori infection, gastric atrophy and gastric cancer in Japanese. Asian Pac J Cancer Prev, 11, 669-73.
14. Iishi H, Tatsuta M, Baba M, et al (1998). Promotion by the alpha-adrenoceptor agonist phenylephrine, but not by the beta-adrenoceptor agonist isoproterenol, of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats. Cancer Lett, 122, 61-5.
15. Levine PH, Stemmermann G, Lennette ET, et al (1995). Elevated antibody titers to epstein-barr virus prior to the diagnosis of Epstein-Barr-virus-associated gastric adenocarcinoma. Int J Cancer, 60, 642-4.
16. Liu Z, Xu X, Chen L, et al (2012). Helicobacter pylori CagA inhibits the expression of RUNX3 via Src/MEK/ERK and p38 MAPK pathways in gastric epithelial cell. J Cell Biochem, 113, 1080-6.
17. Ming SC, Bajtai A, Correa P, et al (1984). Gastric dysplasia. Significance and pathologic criteria. Cancer, 54, 1794-801.
18. Morson BC, Sobin LH, Grundmann E, et al (1980). Precancerous conditions and epithelial dysplasia in the stomach. J Clin Pathol, 33, 711-21.
19. Onitilo AA, Nietert PJ, Egede LE (2006). Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site. Gen Hosp Psychiatry, 28, 396-402.
20. Owen DA (1997). Alimentary canal, stomach. In 'Histology for Pathologists'. Sternberg SS (ed). Philadelphia, Lippincott Williams and Wilkins, 481-95.
21. Owen DA (2004). Alimentary canal and associated organs the stomach. in' sternberg's diagnostic surgical pathology', Carter D, Greenson JK, Oberman HA, Reuter V, Stoler MH, Emills S, (eds). Philadelphia, Lippincott Williams Wilkins, 1435-75.
22. Ren LL, Fang JY (2011). Should we sound the alarm? Dysplasia and colitis-associated colorectal cancer. Asian Pac J Cancer Prev, 12, 1881-6.
23. Sugimura, T, M Terada (1998). Experimental chemical carcinogenesis in the stomach and colon. Jpn J Clin Oncol, 28, 163-7.
24. Suleyman H, Cadirci E, Albayrak A, et al (2010). Occurrence of anticancer activity of prednisolone via adrenalectomy and inhibition of adrenaline in rats. Int J Cancer, 126, 1740-8.
25. Suleyman H, Cadirci E, Albayrak A, et al (2009). Comparative study on the gastroprotective potential of some antidepressants in indomethacin-induced ulcer in rats. Chem Biol Interact, 180, 318-24.
26. Tatematsu M, Takahashi M, Fukushima S, et al (1975). Effects in rats of sodium chloride on experimental gastric cancers induced by N-methyl-N-nitro-N-nitrosoguanidine or 4-nitroquinoline-1-oxide. J Natl Cancer Inst, 55, 101-6.
27. Tatsuta M, Iishi H, Baba M, Taniguchi H (1989). Promotion by nialamide of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats. Jpn J Cancer Res, 80, 521-5.
28. Tatsuta M, Iishi H, Baba M, Taniguchi H (1991). Enhanced induction of gastric carcinogenesis by N-methyl-N'-nitro-N-nitrosoguanidine in deoxycorticosterone acetate-NaCl hypertensive rats and its inhibition by potassium chloride. Cancer Res, 51, 2863-6.
29. Tatsuta M, Iishi H, Baba M, Taniguchi H (1991). Enhancement by tyrosine methyl ester of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats. Int J Cancer, 48, 785-8.
30. Tatsuta M, Iishi H, Baba M, Taniguchi H (1992). Inhibition of azoxymethane-induced experimental colon carcinogenesis in Wistar rats by 6-hydroxydopamine. Int J Cancer, 50, 298-301.
31. Tatsuta M, Iishi H, Baba M, et al (1993). Enhancing effects of calcium-deficient diet on gastric carcinogenesis by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats. Jpn J Cancer Res, 84, 945-50.
32. Tatsuta M, Iishi H, Baba M, et al (1998). Alpha1-adrenoceptor stimulation enhances experimental gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats. Int J Cancer, 77, 467-9.
33. Thompson DE, Mabuchi K, Ron E, et al (1994). Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat Res, 137, 17-67.